Shaan Dudani

1.6k total citations
48 papers, 765 citations indexed

About

Shaan Dudani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Shaan Dudani has authored 48 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Shaan Dudani's work include Renal cell carcinoma treatment (28 papers), Cancer Genomics and Diagnostics (22 papers) and Renal and related cancers (10 papers). Shaan Dudani is often cited by papers focused on Renal cell carcinoma treatment (28 papers), Cancer Genomics and Diagnostics (22 papers) and Renal and related cancers (10 papers). Shaan Dudani collaborates with scholars based in Canada, United States and Denmark. Shaan Dudani's co-authors include Daniel Y.C. Heng, Toni K. Choueiri, Frede Donskov, Jeffrey Graham, Chun Loo Gan, Aaron R. Hansen, Sumanta K. Pal, Benoit Beuselinck, J. Connor Wells and Georg A. Bjarnason and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Shaan Dudani

46 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaan Dudani Canada	14	536	420	271	246	141	48	765
Martin Smoragiewicz Canada	9	410 0.8×	301 0.7×	205 0.8×	180 0.7×	84 0.6×	36	601
Lina Yin China	8	463 0.9×	397 0.9×	209 0.8×	161 0.7×	125 0.9×	17	673
Tom Waddell United Kingdom	7	567 1.1×	427 1.0×	269 1.0×	207 0.8×	131 0.9×	18	715
Vicente Alonso-Orduña Spain	7	402 0.8×	832 2.0×	143 0.5×	135 0.5×	148 1.0×	23	1.0k
Vincenzo Emanuele Chiurì Italy	12	456 0.9×	478 1.1×	213 0.8×	189 0.8×	67 0.5×	35	703
John A. Steinharter United States	13	431 0.8×	541 1.3×	231 0.9×	161 0.7×	134 1.0×	30	778
Omi Parikh United Kingdom	11	461 0.9×	226 0.5×	306 1.1×	224 0.9×	89 0.6×	34	590
Claus-Christoph Steffens Germany	7	481 0.9×	972 2.3×	148 0.5×	149 0.6×	132 0.9×	18	1.1k
Federico Nasroulah United States	11	395 0.7×	824 2.0×	206 0.8×	150 0.6×	159 1.1×	29	993
Shruti Shally Saggi United States	8	488 0.9×	389 0.9×	199 0.7×	165 0.7×	110 0.8×	9	591

Countries citing papers authored by Shaan Dudani

Since Specialization

Citations

This map shows the geographic impact of Shaan Dudani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaan Dudani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaan Dudani more than expected).

Fields of papers citing papers by Shaan Dudani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaan Dudani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaan Dudani. The network helps show where Shaan Dudani may publish in the future.

Co-authorship network of co-authors of Shaan Dudani

This figure shows the co-authorship network connecting the top 25 collaborators of Shaan Dudani. A scholar is included among the top collaborators of Shaan Dudani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaan Dudani. Shaan Dudani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sheffield, Brandon S., Shantanu Banerji, Shaan Dudani, et al.. (2025). Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada. Current Oncology. 32(3). 141–141.

Carter, Michael D., Shaan Dudani, Jonathan M. Loree, et al.. (2024). Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. SHILAP Revista de lepidopterología. 5(1). 1–10. 4 indexed citations

Dudani, Shaan, Marco Iafolla, Kashif Irshad, et al.. (2024). Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center. Cancers. 16(14). 2505–2505. 6 indexed citations

Graham, Jeffrey, J. Connor Wells, Shaan Dudani, et al.. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 171. 124–132. 20 indexed citations

Sheffield, Brandon S., Marco Iafolla, Shaan Dudani, et al.. (2022). Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care. Current Oncology. 29(3). 1326–1334. 31 indexed citations

Cheema, Parneet, et al.. (2022). A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre. Current Oncology. 29(2). 869–880. 3 indexed citations

Shee, Kevin, Sumanta K. Pal, J. Connor Wells, et al.. (2021). Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. JCO Clinical Cancer Informatics. 5(5). 912–920. 1 indexed citations

Gan, Chun Loo, Igor Stukalin, Daniel E. Meyers, et al.. (2021). Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials. European Journal of Cancer. 151. 115–125. 32 indexed citations

Gupta, Alind, Paul Arora, Darren R. Brenner, et al.. (2021). Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma. JCO Clinical Cancer Informatics. 5(5). 326–337. 1 indexed citations

10.

Wells, J. Connor, Shaan Dudani, Chun Loo Gan, et al.. (2021). Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. Clinical Genitourinary Cancer. 19(4). 354–361. 11 indexed citations

11.

Araújo, Daniel Vilarim, J. Connor Wells, Aaron R. Hansen, et al.. (2021). Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis. Journal of Geriatric Oncology. 12(5). 820–826. 18 indexed citations

12.

Wells, J. Connor, Shaan Dudani, Gan Chen, et al.. (2020). Real-world clinical effectiveness of second-line sunitinib following immuno-oncology therapy in patients with metastatic renal cell carcinoma. European Urology Open Science. 19. e1105–e1106. 1 indexed citations

13.

Chen, Gan, Daniel E. Meyers, Igor Stukalin, et al.. (2020). 425P The impact of obesity on treatment outcomes in patients with solid tumour malignancies treated with first-line (1L) immuno-oncology (IO) agents. Annals of Oncology. 31. S1408–S1408. 2 indexed citations

14.

Dudani, Shaan, Rachel Goodwin, Patricia A. Tang, et al.. (2020). The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer. Public Health in Practice. 1. 100012–100012. 5 indexed citations

15.

Dudani, Shaan, et al.. (2019). An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma. European Urology Focus. 6(1). 34–36. 24 indexed citations

16.

Dudani, Shaan, Patricia A. Tang, Jose Gerard Monzon, et al.. (2019). Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 19(1). 664–664. 50 indexed citations

17.

Dudani, Shaan, Xiaofu Zhu, Daniel Yokom, et al.. (2017). Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes. Clinical Lung Cancer. 19(1). e11–e18. 4 indexed citations

18.

Dudani, Shaan, Sasha Mazzarello, John Hilton, et al.. (2016). Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review. Clinical Breast Cancer. 16(6). 456–470. 22 indexed citations

19.

Dudani, Shaan, Natasha B. Leighl, Cheryl Ho, et al.. (2016). Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists. Lung Cancer. 94. 74–80. 7 indexed citations

20.

Fernandes, Ricardo, Sasha Mazzarello, Carol Stober, et al.. (2016). Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review. Breast Cancer Research and Treatment. 161(1). 1–10. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact